Edit
About This Webinar
"All speakers gave a very interesting prospective on the topic." "I loved the discussion." -Audience Feedback

Insights and data on New Opportunities and Challenges for Microfluidics in medical device systems. Experts in microfluidics and medical device research, technology, development, and commercialization share experiences and learnings from successes and ongoing projects.

View rerording of 90-minute live webinar.

This Virtual Medical Device Playbook is moderated by Lynne Lowry, Senior Vice President of StarFish Medical.
Agenda
  • Microfluidics in the real world: When microfluidic technology is required, the problems of implementing microfluidics in commercial products, and examples of how to solve many of the challenges to produce high volume robust products.
  • Visualizing Rare Cell Biology: New microfluidic technology that enables protein expression to be monitored at the single cell level for rare cells with phenotypes relevant to the development of new therapeutics.
  • Simoa Sensitivity: Empowering the Earliest Disease Detection and Monitoring in Blood
  • Microfluidics and Hypermobility for Health 4.0: New imperatives of healthcare are focusing on prevention, personalization of diagnostics and treatment, and democratization, including access to everyone, anywhere, anytime at a low cost. The technology convergence in medicine is enabled by the powerful combination of microelectronics, microfluidics, distributed network and data analytics.
  • Integrating microfluidics and medical device product development: Exciting microfluidic technologies and fabrication techniques that miniaturize laboratory processes have been adapted for disease diagnostics. Mastering the intersection of microfluidic technologies with medical device product development processes will lead to a more successful commercial product.
Presenters
1597853496-fcdf2dec06a12641
Lynne Lowry
Senior Vice President - StarFish Medical
Lynne is a seasoned Business Development Executive in the medical diagnostic industry. Skilled in Sales Management, Sales, Medical Devices, Marketing Management, and Market Analysis, she has held multiple roles in the diagnostic, life science and medical device space in her 30 year career. Prior to joining StarFish Medical, Lynne consulted for product development firms and led global business development teams for Invetech and IDEX Health and Science.
1597853974-5f4a82ce0b139f57
Kevin Hrusovsky
President, Chairman and Chief Executive Officer - Quanterix
Kevin Hrusovsky has dedicated his 30-year career to leading disruptive medical technology companies and shepherding a global movement to transform healthcare to Precision Health. He created Powering Precision Health foundation, an internationally renowned non-profit promoting a new era of medicine using biomarker innovation to achieve precision medicine. Kevin has always been committed to accelerating adoption and value creation for many “game changing” non-invasive early detection technologies for Oncology, Neurodegeneration and Cardiology which are transforming drug development and disease prevention.

Before Quanterix, he was CEO of Caliper Life Sciences, and Zymark Corporation, as well as, President of Life Sciences at PerkinElmer. He is the recipient of several distinguished awards including the 2019 EY Entrepreneur of the Year®, the 2018 Lifetime Achievement Award for Leadership and the E.G. Bailey Entrepreneurship Award (2013), both from The Ohio State University.
1597854903-79e6d07db7fd62a3
Dr. Ali Tinazli
Chief Commercial Officer - Fluxergy
Dr. Tinazli joined Fluxergy in October 2019. He oversees all commercial operations, strategic planning, business development, sales, and strategic partnerships. Prior to his role at Fluxergy as Chief Commercial Officer, Dr. Ali Tinazli led the corporate-wide, global strategy for Healthcare and Life Sciences for Hewlett-Packard (HP Inc.). After receiving his Ph.D., Ali worked in Corporate Development at Applied Biosystems (now: Thermo Fisher) and built a life sciences business at SONY. He also currently serves as angel investor and board member at various start-ups ranging from cybersecurity to oncology.
1597878166-55cd304df482818c
Lorenzo Gutierrez, Ph.D., PMP
Microfluidic Application and Integration Lead – StarFish Medical
Lorenzo Gutierrez has over 30 years of product development experience in semiconductor, consumer electronics, and medical devices. He started working with microfluidics at the University of Tokyo in Japan in 1999, and continued developing microfluidic systems at the University of Toronto in 2011. Lorenzo has developed new fabrication techniques, materials, processes, and methods in commercializing cartridges and instruments. His microfluidic applications include cell-based, immuno and molecular assays. Lorenzo specializes in overall system design, hardware engineering, integration, and translation of assay workflow to consumable cartridges. At Starfish Medical, Lorenzo manages the microfluidic cartridge development team and serves as interim site director in Toronto.
1597861497-091aabd3b34f605b
Shana Kelley
Distinguished Professor, University of Toronto
Dr. Shana Kelley is a University Professor at the University of Toronto and a member of the Departments of Chemistry, Biochemistry, Pharmaceutical Sciences and Biomedical Engineering. The Kelley research group works in a variety of areas spanning biophysical/bioanalytical chemistry, chemical biology and nanotechnology, and has pioneered new methods for tracking molecular and cellular analytes with unprecedented sensitivity.

Dr. Kelley’s work has been recognized with a variety of distinctions, including being named one of “Canada’s Top 40 under 40”, a NSERC E.W.R. Steacie Fellow, the 2011 Steacie Prize, and the 2016 NSERC Brockhouse Prize. She has also been recognized with the ACS Inorganic Nanoscience Award, the Pittsburgh Conference Achievement Award, an Alfred P. Sloan Research Fellowship, a Camille Dreyfus Teacher-Scholar award, a NSF CAREER Award, a Dreyfus New Faculty Award, and was also named a “Top 100 Innovator” by MIT’s Technology Review.

Kelley is an inventor on over 50 patents issued worldwide. She is a founder of three molecular diagnostics companies, GeneOhm Sciences (acquired by Becton Dickinson in 2005), Xagenic Inc. (acquired by General Atomics in 2017), and Cellular Analytics.

Dr. Kelley is the Director of PRiME, an initiative focused on next-generation Precision Medicine that unites physical scientists, engineers, biologists and clinicians developing new therapeutics and diagnostics. Kelley serves as a Board Director for the Fight Against Cancer Innovation Trust (FACIT) and the Canadian Academy of Health Sciences. She is an Associate Editor for ACS Sensors, and an Editorial Advisory Board Member for the Journal of the American Chemical Society, Nano Letters, and ACS Nano.

1597856446-4b14e47dce71d79c
Stevan Jovanovich, Ph.D.
Founder, President & CEO - S2 Genomics, Inc.
Dr. Stevan Jovanovich is the President/CEO of both S2 Genomics, Inc. S2 Genomics was founded in 2016 to develop integrated sample preparation systems for genomics focusing on preparing single cells and nuclei from solid tissue samples. Previously, he was President/CEO/Founder and CTO of IntegenX, Inc., the global leader in rapid human identification, now part of Thermo Fisher. Dr. Jovanovich is a co-founder and Director of Functional Biosciences, Inc., a leading CLIA Sanger sequencing laboratory.

Before co-founding IntegenX, Dr. Jovanovich was Vice President of Global Research at Amersham Biosciences. Prior positions include Science Director at Amersham Biosciences Sunnyvale, Manager of Advanced Research at Molecular Dynamics, Staff Scientist at Lawrence Berkeley National Laboratory, Director of Microbiology at AbTox Inc, founder of Molecular Solutions, and Applications Programmer at the Institute for Defense Analyses.

He is author of 28 peer-reviewed papers and reviews, an inventor on over 140 international patents, and has automated life science workflows since 1987. He is a technical expert in the fields of genomics, rapid DNA, microfluidics, and systems integration.

He holds Bachelor of Science degrees in Physics and Life Sciences from MIT, a Ph.D. in Microbiology from University of California at Davis with a minor in Molecular Biology, and a Certificate in Object-Oriented Programming from the University of California Santa Cruz Extension.